1 Min Read
June 21 (Reuters) - Innate Immunotherapeutics Ltd:
* Received clearance from U.S. FDA for company’s investigational new drug (IND) application lodged last month Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.